Skip to main content

Telomir Pharmaceuticals, Inc.

TELO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001971532

No open-market purchases or sales by Telomir Pharmaceuticals, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $3.80M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +6 vs. previous quarter
33
13F valueReported value at the end of Q2 2026
$3.80M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding TELO, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding TELO at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Telomir Pharmaceuticals, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 15, 2024 (view filing)4:11 PM ETFeb 132 daysBay Shore Trust and 1 other10% OwnerPPurchase+138.0K$7.00+$966.0K+7.8%1.90M after3 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in Telomir Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 33 holders
Institutions holding TELO in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Capital Management LLC1,613,639$2.07M0.00%+618,266+62.1%Added
Geode Capital Management, LLC338,875$433.9K0.00%+89,789+36.0%Added
BlackRock, Inc.280,472$359.0K0.00%−8,726−3.0%Reduced
Vanguard Fiduciary Trust Co225,304$288.4K0.00%+89,763+66.2%Added
Northern Trust Corp61,532$78.8K0.00%+19,688+47.1%Added
State Street Corp58,600$75.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp51,454$65.9K0.00%00.0%Unchanged
Captrust Financial Advisors51,194$65.5K0.00%+51,194New
Advisor Group Holdings, Inc.41,490$53.1K0.00%+5,695+15.9%Added
Pensionmark Financial Group, LLC37,037$48.1K0.00%00.0%Unchanged